Literature DB >> 11377406

Placebos and paradoxes in psychiatric research: an ethics perspective.

L W Roberts1, J Lauriello, C Geppert, S J Keith.   

Abstract

The use of placebos in clinical trials, particularly in research with mentally ill people, has emerged as a subject of considerable controversy. We first outline ethical aspects of the primary scientific arguments for and against placebo use in research. Three examples of paradoxical aspects of the ethical use of placebos are discussed: involvement of relatively more vulnerable populations, use of apparently "less than standard" therapy, and the omission of information in placebo comparisons. In the current scientific and regulatory context, placebo use in psychiatric research may be necessary for scientific reasons, and when certain conditions are present, it may be justified on ethical grounds. Four key recommendations to facilitate the ethical use of placebos in research trials are presented. We conclude that placebo trials should be undertaken only after careful evaluation of alternative scientific strategies and, as with all human research, with great respect and genuine consideration for the individuals who choose to participate in these protocols.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377406     DOI: 10.1016/s0006-3223(01)01111-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  7 in total

Review 1.  Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies.

Authors:  Ellen Frank; Danielle M Novick; David J Kupfer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

Review 2.  Ethical concerns about non-active conditions in smoking cessation trials and methods to decrease such concerns.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-12-06       Impact factor: 4.492

3.  The Ethics of Clinical Trials Research in Severe Mood Disorders.

Authors:  Allison C Nugent; Franklin G Miller; Ioline D Henter; Carlos A Zarate
Journal:  Bioethics       Date:  2017-05-15       Impact factor: 1.898

Review 4.  Teaching ethics of psychopharmacology research in psychiatric residency training programs.

Authors:  Eugene V Beresin; Ross J Baldessarini; Jonathan Alpert; Jerrold Rosenbaum
Journal:  Psychopharmacology (Berl)       Date:  2003-04-02       Impact factor: 4.530

5.  Understanding of placebo controls among older people with schizophrenia.

Authors:  Laura B Dunn; Barton W Palmer; Monique Keehan
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

Review 6.  Ethics of pharmacological research involving adolescents.

Authors:  Eva Welisch; Luis A Altamirano-Diaz
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

7.  The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children.

Authors:  Adam G Dunn; Kenneth D Mandl; Enrico Coiera; Florence T Bourgeois
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.